P507: SALVAGE THERAPY WITH VENETOCLAX IN COMBINATION WITH AZACITIDINE, HOMOHARRINGTONINE AND CYTARABINE IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
Linyu Yuan,
Suo Xiaohui,
Guanchen Bai,
Hong LI,
Zhongjing Han,
Congcong Zhang,
Yinling LI,
Sifeng Gao,
Jilei Zhang,
Xinxiao Lu,
Kaiqi Liu,
Zhao Xingli
Affiliations
Linyu Yuan
1 Tianjin People’s Hospital, Department of Hematology, Tianjin, China
Suo Xiaohui
2 Handan Central Hospital, Department of Hematology, Handan, Hebei, China
Guanchen Bai
3 The Affiliated Tai’an City Central Hospital of Qingdao University, Department of Hematology, Taian, Shandong, China
Hong LI
4 Daqing Oilfield General Hospital, Department of Hematology, Daqing，Heilongjing, China
Zhongjing Han
4 Daqing Oilfield General Hospital, Department of Hematology, Daqing，Heilongjing, China
Congcong Zhang
2 Handan Central Hospital, Department of Hematology, Handan, Hebei, China
Yinling LI
2 Handan Central Hospital, Department of Hematology, Handan, Hebei, China
Sifeng Gao
3 The Affiliated Tai’an City Central Hospital of Qingdao University, Department of Hematology, Taian, Shandong, China
Jilei Zhang
3 The Affiliated Tai’an City Central Hospital of Qingdao University, Department of Hematology, Taian, Shandong, China
Xinxiao Lu
5 Tianjin People’s Hospital, Department of Hematology, Tianjin, China
Kaiqi Liu
6 State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, leukemia center, Tianjin, China
Zhao Xingli
5 Tianjin People’s Hospital, Department of Hematology, Tianjin, China
